Biose Industrie

Clermont-ferrand, France Founded: 2013 • Age: 13 yrs Acquired By L-GAM
Therapeutic macrobiotic ranges for human health are provided globally.
Request Access

About Biose Industrie

Biose Industrie is a company based in Clermont-ferrand (France) founded in 2013 was acquired by L-GAM in February 2023. It operates as a Professional Services. Biose Industrie has raised $34.25 million across 2 funding rounds from investors including Bpifrance, Cathay Capital and L-GAM. Biose Industrie offers products and services including Microbiome Therapeutics and Next Generation Probiotics. Biose Industrie operates in a competitive market with competitors including KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.

  • Headquarter Clermont-ferrand, France
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Biose Industrie
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $34.25 M (USD)

    in 2 rounds

  • Latest Funding Round
    $34.25 M (USD), Series C

    Jul 16, 2020

  • Investors
    Bpifrance

    & 2 more

  • Employee Count
    Employee Count
  • Acquired by
    L-GAM

    (Feb 22, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Biose Industrie

Biose Industrie offers a comprehensive portfolio of products and services, including Microbiome Therapeutics and Next Generation Probiotics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Microbiome therapeutics are developed for innovative drug solutions.

Next generation probiotics are produced for health benefits.

Funding Insights of Biose Industrie

Biose Industrie has successfully raised a total of $34.25M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $34.25 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series C — $34.2M
  • First Round

    (01 Jan 2019)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2020 Amount Series C - Biose Industrie Valuation Cathay Capital
Jan, 2019 Amount Grant - Biose Industrie Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Biose Industrie

Biose Industrie has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, Cathay Capital and L-GAM. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Cathay Capital is engaged in global investment and transformation.
Founded Year Domain Location
L-GAM is engaged in mid-market investments across Europe.
Founded Year Domain Location
Corporate consultancy, advisory, and funding services are provided to businesses.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Biose Industrie

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Biose Industrie

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Biose Industrie Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Biose Industrie

Biose Industrie operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of protein formulation, process & cell line development, and cGMP services
domain founded_year HQ Location
Biologics development and manufacturing services are offered by EirGenix.
domain founded_year HQ Location
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
domain founded_year HQ Location
Developer of therapeutics for microbiome based diseases
domain founded_year HQ Location
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
domain founded_year HQ Location
Vaccines and biologics are developed and manufactured by IDT Biologika.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Biose Industrie

When was Biose Industrie founded?

Biose Industrie was founded in 2013 and raised its 1st funding round 6 years after it was founded.

Where is Biose Industrie located?

Biose Industrie is headquartered in Clermont-ferrand, France. It is registered at Clermont-ferrand, Auvergne-rhone-alpes, France.

Is Biose Industrie a funded company?

Biose Industrie is a funded company, having raised a total of $34.25M across 2 funding rounds to date. The company's 1st funding round was a Grant of $314.94K, raised on Jan 01, 2019.

What does Biose Industrie do?

Biose Industrie is established as a global Contract Development and Manufacturing Organization (CDMO) specializing in microbiome therapeutics and next generation probiotics. The company is focused on bioproduction, integrating analytical and industrial expertise to support clients from project development to commercial launch. Services are provided in the healthcare and biotechnology sectors, addressing innovative drug categories using microorganisms. Facilities are maintained in France and the USA to cater to international markets. Regulatory requirements and market needs are anticipated to ensure client satisfaction and project success.

Who are the top competitors of Biose Industrie?

Biose Industrie's top competitors include KBI Biopharma, Aldevron and Ovagen.

What products or services does Biose Industrie offer?

Biose Industrie offers Microbiome Therapeutics and Next Generation Probiotics.

Who are Biose Industrie's investors?

Biose Industrie has 3 investors. Key investors include Bpifrance, Cathay Capital, and L-GAM.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available